Selected article for: "atherosclerosis development and inflammatory response"

Author: Luo, Jin-Wen; Hu, Yuan; Liu, Jian; Yang, Huan; Huang, Peng
Title: Interleukin-22: a potential therapeutic target in atherosclerosis
  • Cord-id: 43qlqh4i
  • Document date: 2021_8_13
  • ID: 43qlqh4i
    Snippet: BACKGROUND: Atherosclerosis is recognized as a chronic immuno-inflammatory disease that is characterized by the accumulation of immune cells and lipids in the vascular wall. In this review, we focus on the latest advance regarding the regulation and signaling pathways of IL-22 and highlight its impacts on atherosclerosis. MAIN BODY: IL-22, an important member of the IL-10 family of cytokines, is released by cells of the adaptive and innate immune system and plays a key role in the development of
    Document: BACKGROUND: Atherosclerosis is recognized as a chronic immuno-inflammatory disease that is characterized by the accumulation of immune cells and lipids in the vascular wall. In this review, we focus on the latest advance regarding the regulation and signaling pathways of IL-22 and highlight its impacts on atherosclerosis. MAIN BODY: IL-22, an important member of the IL-10 family of cytokines, is released by cells of the adaptive and innate immune system and plays a key role in the development of inflammatory diseases. The binding of IL-22 to its receptor complex can trigger a diverse array of downstream signaling pathways, in particular the JAK/STAT, to induce the expression of chemokines and proinflammatory cytokines. Recently, numerous studies suggest that IL-22 is involved in the pathogenesis of atherosclerosis by regulation of VSMC proliferation and migration, angiogenesis, inflammatory response, hypertension, and cholesterol metabolism. CONCLUSION: IL-22 promotes the development of atherosclerosis by multiple mechanisms, which may be a promising therapeutic target in the pathogenesis of atherosclerosis.

    Search related documents:
    Co phrase search for related documents
    • adaptive immunity and low concentration: 1
    • adaptive immunity and low density: 1, 2, 3
    • adaptive immunity and lps lipopolysaccharide: 1
    • adaptive immunity and lymphocyte cell: 1, 2, 3, 4, 5, 6, 7, 8
    • adaptive immunity and lymphoid cell: 1, 2, 3, 4
    • adaptive immunity and macrophage inflammatory response: 1
    • adaptive immunity and macrophage phenotype: 1, 2
    • adaptive immunity and macrophage polarization: 1, 2, 3, 4
    • adhesion molecule and low density: 1, 2, 3, 4, 5, 6
    • adhesion molecule and low density lipoprotein: 1, 2, 3, 4, 5, 6
    • adhesion molecule and lowdensity lipoprotein: 1
    • low density and lowdensity lipoprotein: 1, 2
    • low density and lps lipopolysaccharide: 1, 2, 3, 4
    • low density and lps lipopolysaccharide stimulation: 1, 2
    • low density and lymphocyte cell: 1, 2
    • low density and macrophage differentiation: 1
    • low density and macrophage inflammation: 1
    • low density and macrophage phenotype: 1
    • low density and macrophage polarization: 1, 2